Charles A Baker's Net Worth

$36 Million

Estimate Recalculated Nov 7, 2024 11:33AM EST

Who is Charles A Baker?

Charles A Baker has an estimated net worth of $36 Million. This is based on reported shares across multiple companies, which include REGENERON PHARMACEUTICALS INC, and PROGENICS PHARMACEUTICALS INC.

SEC CIK

Charles A Baker's CIK is 0001225470

Past Insider Trading and Trends

2007 was Charles A Baker's most active year for acquiring shares with 19 total transactions. Charles A Baker's most active month to acquire stocks was the month of January. 2007 was Charles A Baker's most active year for disposing of shares, totalling 34 transactions. Charles A Baker's most active month to dispose stocks was the month of January. 2014 saw Charles A Baker paying a total of $357,600.00 for 27,750 shares, this is the most they've acquired in one year. In 2014 Charles A Baker cashed out on 30,000 shares for a total of $4,540,001.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

REGENERON PHARMACEUTICALS INC (REGN) Snapshot price: $1131.5

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
$234.31
-$862,780.00
9K
Scheduled
Sep 29
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
$205.32
-$1,120,218.00
9K
Scheduled
Dec 12
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
$284.31
-$2,656,950.00
9K
Scheduled
Sep 17
Form 4
—
0
$236.79
-$2,181,735.05
9K
Scheduled
Mar 25
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
$163.26
-$4,182,401.00
9K
Scheduled
Mar 24
Form 4
-100.00%
-590.00
—
—
0
Nov 26 - Jan 2
Form 4
—
0
$166.86
-$4,415,088.94
9K
Scheduled
Sep 30
Form 4
—
0
$133.82
-$3,540,547.42
9K
Scheduled
Jun 10
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
$91.52
-$2,470,435.95
9.59K
Scheduled
Nov 26
Form 4
—
0
$82.51
-$2,024,850.00
9.59K
Scheduled
Sep 5 - Sep 6
Form 4
—
0
$71.90
-$1,593,000.00
9.59K
Scheduled
Apr 17 - Apr 19
Form 4
—
0
—
—
0
Jan 3
Form 4
+71.56%
4K
$28.81
$115,240.00
9.59K
Aug 10
Form 4
—
0
$42.97
-$311,562.08
5.59K
Scheduled
Jul 1
Form 4
—
0
—
—
0
Jan 3
Form 4
+847.46%
5K
$25.43
$127,150.00
5.59K
Jun 2
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
$12.91
-$105,000.00
590
Scheduled
Feb 20
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
$13.38
-$109,324.15
590
Scheduled
Feb 15
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
$15.95
-$19,650.60
590
Scheduled
Feb 16
Form 4
—
0
$15.87
-$100,376.88
590
Scheduled
Feb 16
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
$13.67
-$33,353.11
590
Scheduled
Feb 1
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
$6.32
-$3,966.12
590
Scheduled
Feb 22
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
$14.40
-$4,021.00
590
Scheduled
Feb 2
Form 4
—
0
—
—
0
Jan 2
No matching records found

PROGENICS PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Jul 2
Form 4
—
0
$24.76
-$26,300.00
21.48K
Scheduled
Jan 29
Form 4
—
0
—
—
0
Jul 3
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
$10.17
-$266,325.00
27.5K
Apr 1 - Jul 3
No matching records found